This finding, coupled with the observed rapidity of tumor control (Fig. 1d–g) and upregulation of the tumoricidal molecule granzyme B (Fig. 1c), suggests direct killing of peptide-coated tumor cells by reactivated antiviral T cells may have occurred, as has been previously described for vaccine-generated T cells13. The gene discussed is GZMB; the disease is neoplasm.